fulvestrant has been researched along with Sarcoma, Endometrial Stromal in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arts, HJ; Glaudemans, AW; Hollema, H; Hospers, GA; Reyners, AK; van Kruchten, M | 1 |
1 review(s) available for fulvestrant and Sarcoma, Endometrial Stromal
| Article | Year |
|---|---|
Positron emission tomography imaging of oestrogen receptor-expression in endometrial stromal sarcoma supports oestrogen receptor-targeted therapy: case report and review of the literature.
Topics: Adult; Endometrial Neoplasms; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Positron-Emission Tomography; Receptors, Estrogen; Sarcoma, Endometrial Stromal; Time Factors; Treatment Outcome; Tumor Burden | 2013 |